Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03815643
Title Avelumab Program Rollover Study
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries USA | BEL


No variant requirements are available.